HOME >> BIOLOGY >> NEWS
Hopkins researchers discover how nitric oxide prevents blood vessel inflammation

Johns Hopkins scientists investigating nitric oxide (NO) - the molecular messenger that contributes to body functions as wide-ranging as cell death, new blood vessel growth and erections - have figured out how it can block blood vessel inflammation and prevent clotting, a process that has long stumped biologists.

Reporting in the Oct. 17 issue of the journal Cell, cardiologist Charles J. Lowenstein, M.D., and his team observed that NO has the power to inhibit endothelial cells lining blood vessels from releasing inflammatory substances.

Normally, these cells activate a process called exocytosis (a release of substances) to start inflammation, releasing packets of molecules into the bloodstream that, like tiny hand grenades, explode and discharge compounds that trigger inflammation. NO can move in and target a protein within the endothelial cells, N-ethylmaleimide-Sensitive Factor (NSF), that stops the process from happening by blocking the ability of NSF to push out the molecules.

"Nitric oxide may regulate exocytosis this way in a variety of diseases," says Lowenstein, an associate professor of medicine at Hopkins. "For example, nitric oxide blocks exocytosis from platelets, preventing blood clots; exocytosis from neurons, decreasing neurotoxicity in strokes; and exocystosis from lymphocytes, reducing autoimmune damage."

The Hopkins scientists discovered NO's protective role in both cells and mice. They added NO to human endothelial cells in culture and discovered that it blocked the release of inflammatory compounds. The researchers then found that platelets stuck to blood vessels more often in mice that could not make NO, compared to normal mice.

The findings already have led Lowenstein's team to develop a novel drug to block exocytosis, thereby acting as an anti-clotting agent. It is a peptide that blocks exocytosis by a mechanism similar to that of nitric oxide. In laboratory tests in mice, the drug prevented tiny, d
'"/>

Contact: Karen Blum
kblum@jhmi.edu
410-955-1534
Johns Hopkins Medical Institutions
17-Oct-2003


Page: 1 2

Related biology news :

1. Hopkins scientists use blood proteins to detect ovarian cancer
2. Hopkins to found first center for comprehensive study of epigenetics
3. Hopkins scientists overcome main obstacle to making tons of short, drug-like proteins
4. Hopkins Marine Station honored by the American Society for Microbiology
5. Johns Hopkins gene hunters pinpoint new cancer gene target
6. Hopkins researchers identify transplantation antigens among Sioux Indians
7. Hopkins is first US institution to obtain powerful genotyping system
8. Dr. Robot tested at Hopkins
9. From Hopkins: Children may outgrow peanut allergies
10. OXiGENE announces launch of ophthalmic clinical trial at The Johns Hopkins School of Medicine
11. Hopkins researchers find potential new treatment for children with chronic hepatitis C

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/16/2019)... ... ... SFC Fluidics, Inc. (SFC) has partnered with two companies, Diabeloop ... was awarded to SFC Fluidics in 2018 by JDRF. , JDRF is sponsoring this ... people with type 1 diabetes (T1D). By accelerating the development of a next-generation miniaturized ...
(Date:5/14/2019)... , ... May 13, 2019 , ... ... in the BIOMEDevice Expo in Boston on May 15-16, 2019, the largest medical ... industry including, MedTech, design engineering, and embedded systems product organizations. , They will ...
(Date:5/8/2019)... ... 2019 , ... MMS Holdings – an award-winning, data-focused contract ... Medrio , the leading provider of eClinical technology for small to mid-sized pharmaceutical ... position high-quality CRO services with Medrio’s fast and easy-to-use eClinical products, MMS is ...
Breaking Biology News(10 mins):
(Date:5/4/2019)... ... May 03, 2019 , ... More ... the Dakila Pesquisas Association, the scientist and ufologist Urandir Fernandes de Oliveira, last ... Urandir detailed the results of some research carried out by the association, in ...
(Date:5/2/2019)... ... May 02, 2019 , ... Researchers from Ambry Genetics ... between U.S. insurer policies for genetic testing and the 2019 National Comprehensive Cancer ... ovarian cancer (HBOC). , Jill S. Dolinsky, director of clinical affairs ...
(Date:4/16/2019)... FREDERICK, Md. (PRWEB) , ... April 16, 2019 ... ... will honor Blue Sources and their project partner, the U.S. Army Center for ... Retransfer of Aquatic Biomonitor Through Combined In-Licensing/Out-Licensing.” , Blue Sources, a veteran-owned company ...
(Date:4/10/2019)... ... 2019 , ... After more than three months of renovation, Lajollacooks4u is set ... updated appliances and modern lighting and fixtures, and will provide additional workspace for the ... tremendous growth in the demand for our team-building events and cooking classes over the ...
Breaking Biology Technology:
Cached News: